Relation between infection and autoimmunity in mixed cryoglobulinemia

Current Opinion in Rheumatology

Volumn 12, Issue 1, 2000, Pages 53-60

  Ferri, Clodoveo ^a   Zignego, Anna Linda ^b  

^a UNIVERSITY OF PISA   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AUTOIMMUNITY; CRYOGLOBULINEMIA; DISEASE ASSOCIATION; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNE COMPLEX DEPOSITION; IMMUNOPATHOGENESIS; LYMPHOPROLIFERATIVE DISEASE; PRIORITY JOURNAL; REVIEW; VASCULITIS;

AUTOIMMUNITY; CRYOGLOBULINEMIA; HEPATITIS C; HUMANS;

EID: 0033987991     PISSN: 10408711     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002281-200001000-00009     Document Type: Review

References (73)

1. 1 Gorevic PD, Kassab HJ, Levo Y, Kohn R, Meltzer M, Prose P, Franklin E: Mixed cryoglobulinemia: clinical aspects and long-term follow-up of 40 patients. Am J Med 1980, 69:287-308.
2. 2 Brauet JC, Clouvel JP, Danon F, Klein M, Seligmann M: Biologic and clinical significance of cryoglobulins. Am J Med 1974, 57:775-788.
3. 3 Meltzer M, Franklin EC, Elias K, McCluskey RT, Cooper N: Cryoglobulinemia. A clinical and laboratory study. II. Cryoglobulins with rheumatoid factor activity. Am J Med 1966, 40:837-856.
4. 4 Ferri C, La Civila L, Longombardo G, Zignego AL, Pasero G: Mixed cryoglobulinemia: a cross-road between autoimmune and lymphoproliferative disorders. Lupus 1998, 7:275-279. Good review of clinico-epidemiologic features of mixed cryoglobulinemia, its relation to HCV infection and other HCV-related disorders.
5. 5 Perl A, Gorevic PD, Ryan DH, Condemi JJ, Ruszkowski RJ, Abraham GN: Clonal B cell expansion in patients with essential mixed cryoglobulinemia. Clin Exp Immunol 1989, 76:54-60.
6. 6 Gorevic PD, Frangione B: Mixed cryoglobulinemia cross-reactive idiotypes: implication for relationship of MC to rheumatic and lymphoproliferative diseases. Semin Hematol 1991, 28:79-94.
7. 7 Monteverde A, Rivano MT, Allegra GC, Monteverde AI, Zigrossi P, Baglioni P: Essential mixed cryoglobulinemia, type II: a manifestation of low malignant lymphoma? Clinical-morphological study of 12 cases with special reference to immunohistochemical findings in liver frozen sections. Acta Haematol 1988, 79:20-25.
8. 8 Monteverde A, Sabattini E, Poggi S, Ballare M, Bertoncelli MC, de Vivo A, Briskomatis A, Roncador G, Falini B, Pileri SA: Bone marrow findings further support the hypothesis that essential mixed cryoglobulinemia type II is characterized by a monoclonal B cell proliferation. Leuk Lymphoma 1995, 20:119-124.
9. 9 Gocke DJ, Hsu K, Morgan C, Bombardieri S, Lockshin M, Christian CL: Association between polyarteritis and Australia antigen. Lancet 1970, 2:1149-1153.
10. 10 Levo Y, Gorevic PD, Kassab HJ, Zucker-Franklin D, Franklin EC: Association between hepatitis B virus and essential mixed cryoglobulinemia. N Engl J Med 1977, 296:1501-1504.
11. 11 Bombardieri S, Ferri C, Di Munno O, Pasero G: Liver involvement in essential mixed cryoglobulinemia. La Ricerca Clin Lab 1979, 9:361-368.
12. 12 Popp JW, Dienstag JL, Wands JR, Bloch KJ: Essential mixed cryoglobulinemia without evidence for hepatitis B virus infection. Ann Intern Med 1980, 92:379-383.
13. 13 Choo GL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M: Isolation of a cDNA clone derived from a blood-borne non-A non-B viral hepatitis genome. Science 1989, 244:359-361.
14. 14 Pascual M, Perrin L, Giostra E, Schifer JA: Hepatitis C virus in patients with Cryoglobulinemia type II. J Infect Dis 1990, 162:569-570.
15. 15 Ferri C, Marzo E, Longombardo G, Lombardini F, Greco F, Bombardieri S: Alpha-interferon in the treatment of mixed cryoglobulinemia patients. International Cancer Update. Focus on Interferon Alfa 2b. Cannes, France. November 1-4, 1990. Proceedings. Eur J Cancer 1991, 27:81-82.
16. 16 Ferri C, La Civita L, Longombardo G, Greco F, Bombardieri S: Hepatitis C virus and mixed cryoglobulinemia [review]. Eur J Clin Invest 1993, 23:399-405.
17. 17 Ferri C, Greco F, Longombardo G, Palla P, Moretti A, Marzo E, Mazzoni A, Pasero G, Bombardieri S, Highfield P, Corbishley T: Association between hepatitis C virus and mixed cryoglobulinaemia. Clin Exp Rheumatol 1991, 9:621-624.
18. 18 Agnello V, Chung RT, Kaplan LM: A role for hepatitis C virus infection in type II cryoglubulinemia. N Engl J Med 1992, 327:1490-1495.
19. 19 Sansonno D, De Vita S, Cornacchiulo V, Carbone A, Baiocchi M, Dammacco F: Detection and distribution of hepatitis C-related proteins in lymph nodes of patients with type II cryoglobulinemia and neoplastic or non-neoplastic lymphoproliferation. Blood 1996, 88:4638-4645.
20. 20 Agnello V, Abel G Localization of hepatitis C virus in cutaneous vasculitic lesions in patients with type II cryoglobulinemia. Arthritis Rheum 1997, 40:2007-2015.
21. 21 Monti G, Galli M, Invernizzi F, Pioltelli P, Saccardo F, Monteverde A, Pietrogrande M, Renoldi P, Bombardieri S, Bordin G, Candela M, Ferri C, Gabrielli A, Mazzaro C, Migliaresi S, Mussini C, Ossi E, Quintiliani L, Tirri G, Vacca A, and GISC Italian Group for the Study of Cryoglobulinaemias: Cryoglobulinemias: a multi-centre study of the early clinical and laboratory manifestations of primary and secondary disease. QJM 1995, 88:115-126.
22. 22 Abel G, Zhang QX, Agnello V: Hepatitis C virus infection in type II mixed cryoglobulinemia. Arthritis Rheum 1993, 36:1341-1349.
23. 23 Gumber S, Chopra S: Hepatitis C: a multifaceted disease. Review of extrahepatic manifestations. Ann Intern Med 1995, 123:615-620.
24. 24 Trendelenburg M, Schifferli JA: Cryoglobulins are not essential. Ann Rheum Dis 1998, 57:3-5.
25. 25 Lunel F, Musset L, Cacoub P, Frangeul L, Cresta P, Perrin M, Grippon P, Hoang C, Valla D, Piette JC: Cryoglobulinemia in chronic liver diseases: role of hepatitis C virus and liver damage. Gastroenterology 1994, 106:1291-1300.
26. 26 Pawlotsky J, Mustapha B, Andre C, Voisin M-C, Intrator L, Roudot-Thoraval F, Deforges L, Duvoux C, Zairam E-S, Duval J: Immunological disorders in C virus chronic activ hepatitis: a prospctive case-control study. Hepatology 1994, 19:841-848.
27. 27 Galli M, Invernizzi F, Monteverde A, Monti G, eds: Hepatitis C virus and cryoglobulinemia. Clin Exp Rheumatol 1995, 13/S:S1-S212.
28. 28 sFargion S, Piperno A, Cappellini MD, Sampietro M, Fracanzani AL, Romano R, Caldarelli R, Marcelli R, Vecchi L, Fiorelli G: Hepatitis C virus and porphyria cutanea tarda: evidence of a strong association. Hepatology 1992, 16:1322-1326.
29. 29 Ferri C, Baicchi U, La Civita L, Greco F, Longombardo G, Mazzoni A, Careccia G, Bombardieri S, Pasero G, Zignego AL, Manns MP: Hepatitis C virus-related autoimmunity in patients with porphyria cutanea tarda. Eur J Clin Invest 1993, 23:851-855.
30. 30 Lenzi M, Johnson PJ, McFarlane IG, Ballardini G, Smith HM, McFarlane BM, Bridger C, Vergani D, Bianchi FB, Williams R: Antibodies to hepatitis C virus in autoimmune liver disease: evidence for geographical heterogeneity. Lancet 1991, 338ii:277-280.
31. 31 Magrin S, Craxi A, Fabiano C, Fiorentino G, Almasio P, Palazzo U, Pinzello G, Provenzano G, Pagliaro L, Choo QL, Kuo G, Polito A, Han J, Houghton M: Hepatitis C virus replication in "autoimmune" chronic hepatitis. J Hepatol 1991, 13:364-367.
32. 32 Stehman-Breen C, Willson R, Alpers CE, Gretch D, Johnson RJ: Hepatitis C virus-associated glomerulonephritis. Curr Opin Nephrol Hypertens 1995, 4:287-294.
33. 33 Ferri C, La Civita L, Zignego AL, Pasero G: Viruses and cancer: possible role of hepatitis C virus. Eur J Clin Invest 1997, 27:711-718.
34. 34 Ferri C, Pileri S, Zignego AL: Hepatitis C virus, B-cell disorders, and non-Hodgkin's lymphoma. In Infectious Causes of Cancer. Edited by Goedert JJ. Totowa NJ: Humana Press, 1999: in press.
35. 35 Ferri C, Longombardo G, La Civita L, Greco F, Lombardini F, Cecchetti R, Cagianelli MA, Marchi S, Monti M, Zignego AL, Manns MP: Hepatitis C virus as common cause of mixed cryoglobulinemia and chronic liver disease. J Intern Med 1994, 236:31-36.
36. 36 Czaja AJ: The variant forms of autoimmune hepatitis. Ann Intern Med 1996, 125:588-598.
37. 37 Mishiro S, Takeda K, Hoshi Y, Yoshikawa A, Gotanda T, Itoh Y: An autoantibody cross-reactive to hepatitis C virus core and a host nuclear antigen. Autoimmunity 1991, 10:269-273.
38. 38 King PD, McMurray RW, Becherer PR: Sjögren's syndrome without mixed cryoglobulinemia is not associated with hepatitis C virus infection. Am J Gastroenterol 1994, 89:1047-1050.
39. 39 Jorgensen C, Legouffe MC, Perney P, Coste J, Tissot B, Segarra C, Bologna C, Bourrat L, Combe B, Blanc F, Sany J: Sicca syndrome associated with hepatitis C virus infection. Arthritis Rheum 1996, 39:1166-1171.
40. 40 McMurray RW: Hepatitis C-associated autoimmune disorders. Rheum Dis Clin North Am 1998, 24:353-374. This study suggests the existence of a subset of SSA/SSB-negative Sjögren's syndrome associated with HCV infection.
41. 41 Buskila D, Shnaider A, Neumann L, Lorber M, Zilberman D, Hilzenrat N, Kuperman OJ, Sikuler E: Musculoskeletal manifestations and autoantibody profile in 90 hepatitis C virus infected Israeli patients. Semin Arthritis Rheum 1998, 28:107-113.
42. 42 Jendro MC, Hulsemann JL, Zeidler H: Hepatitis C virus in rheumatic diseases. Z Rheumatol 1997, 56:276-286.
43. 43 Wener MH, Johnson RJ, Sasso EH, Gretch DR: Hepatitis C virus and rheumatic disease. J Rheumatol 1996, 23:953-959.
44. 44 Rivera J, Garcia-Monforte A, Pineda A, Millan Nunez-Cortes J: Arthritis in patients with chronic hepatitis C virus infection. J Rheumatol 1999, 26:420-424. Interesting study focusing on the characteristics of rheumatoid-like manifestations in HCV-seropositive patients and possible therapeutic approaches.
45. 45 Lovy MR, Starkebaum G, Uberoi: Hepatitis C infection presenting with rheumatic manifestations: a mimic of rheumatoid arthritis. J Rheumatol 1996, 23:979-983.
46. 46 Antonelli A, Ferri C, Fallahi P: Thyroid cancer in patients with hepatitis C infection. JAMA 1999, 281:1588. First report on the possible role of HCV in thyroid cancer.
47. 47 Ferri C, La Civita L, Fazzi P, Solfanelli S, Lombardini F, Begliomini E, Monti M, Longombardo G, Pasero G, Zignego AL: Interstitial lung fibrosis and rheumatic disorders in patients with hepatitis C virus infection. Br J Rheumatol 1997, 36:360-365.
48. 48 Weidensaul D, Imam T, Holyst MM, King PD, McMurray RW: Polymyositis, pulmonary fibrosis, and hepatitis C. Arthritis Rheum 1995, 38:437-439.
49. 49 Ferri C, La Civita L, Fazzi P, Pasero G, Zignego AL: Polymyositis, lung fibrosis, and cranial neuropathy in a patient with hepatitis C virus infection. Arthritis Rheum 1996, 39:1074-1075.
50. 50 Lee YH, Ji JD, Yeon JE, Byun KS, Lee CH, Song GG: Cryoglobulinemia and rheumatic manifestations in patients with hepatitis C virus infection. Ann Rheum Dis 1998, 57:728-731. Good study on the extrahepatic manifestations of HCV infection and their relation to cryoglobulinemia.
51. 51 Buskila D, Shnaider A, Neumann L, Zilberman D, Hilzenrat N, Sikuler E: Fibromyalgia in hepatitis C virus infection: another infectious disease relationship. Arch Intern Med 1997, 157:2497-2500.
52. 52 Rivera J, de Diego A, Trinchet M, Garcia Monforte A: Fibromyalgia-associated hepatitis C virus infection. Br J Rheumatol 1997, 36:981-985.
53. 53 Simo R, Hernandez C, Genesca J, Jardi R, Mesa J: High prevalence of hepatitis C virus infection in diabetic patients. Diabetes Care 1996, 19:998-1000.
54. 54 Mason AL, Lau JY, Hoang N, Qian K, Alexander GJ, Xu L, Guo L, Jacob S, Regenstein FG, Zimmerman R, Everhart JE, Wasserfall C, Maclaren NK, Perrillo RP: Association of diabetes mellitus and chronic hepatitis C virus infection. Hepatology 1999, 29:328-333.
55. 55 Lidove O, Cacoub P, Hausfater P, Wechsler B, Frances C, Leger JM, Piette JC: Cryoglobulinemia and hepatitis C: worsening of peripheral neuropathy after interferon alpha treatment. Gastroenterol Clin Biol 1999, 23:403-406.
56. 56 Zignego AL, Macchia D, Monti M, Thiers V, Mazzetti M, Foschi M, Maggi E, Romagnani S, Gentilini P, Brechot C: Infection of peripheral mononuclear blood cells by hepatitis C virus. J Hepatol 1992, 15:382-386.
57. 57 Ferri C, Monti M, La Civita L, Longombardo G, Greco F, Pasero G, Gentilini P, Bombardieri S, Zignego AL: Infection of peripheral blood mononuclear cells by hepatitis C virus in mixed cryoglobulinemia. Blood 1993, 82:3701-3704.
58. 58 Manzin A, Candela M, Paolucci S, Caniglia ML, Gabrielli A, Clementi M: Presence of hepatitis C virus (HCV) genomic intermediates in bone marrow and peripheral blood mononuclear cells from HCV-infected patients. Clin Diagn Lab Immunol 1994, 1:160-163.
59. 59 Zignego AL, Ferri C, Monti M, La Civita L, Giannini C, Careccia G, Pasero G, Bombardieri S, Gentilini P: Hepatitis C virus as a lymphotropic agent: evidence and pathogenetic implications. Clin Exp Rheumatol 1995 (suppl 13), 13:S33-S37.
60. 60 Cacoub P, Boukli N, Hausfater P, Garbarg-Chenon A, Ghillani P, Thibault V, Musset L, Huraux JM, Piette JC: Parvovirus B19 infection, hepatitis C virus infection, and mixed cryoglobulinemia. Ann Rheum Dis 1998, 57:422-424.
61. 61 Tepper JL, Feinman SV, D'Costa L, Sooknannan R, Pruzanski W: Hepatitis G and hepatitis C RNA viruses coexisting in cryoglobulinemia. J Rheumatol 1998, 25:925-928.
62. 62 Migliorini P, Bombardieri S, Castellani A, Ferrara GB: HLA antigens in essential mixed cryoglobulinemia. Arthritis Rheum 1981, 24:932-936.
63. 63 Ossi E, Bordin MC, Businaro MA, Marson P, Bonadonna P, Chiaramonte M, Boin F, Valenti MT, Fagiolo U: HLA expression in type II mixed cryoglobulinemia and chronic hepatitis C virus. Clin Exp Rheumatol 1995 (suppl 13), 13:S91-S93.
64. 64 Lenzi M, Frisoni M, Mantovani V, Ricci P, Muratori L, Francesconi R, Cuccia M, Ferri S, Bianchi FB: Haplotype HLA-B8-DR3 confers susceptibility to hepatitis C virus-related mixed cryoglobulinemia. Blood 1998, 91:2062-2066. This is an interesting study reporting the presence of a particular HLA aplotype in HCV-related MC; however, this intriguing observation clearly differs from previous reports [62,63].
65. 65 Zignego AL, Ferri C, Giannini C, Monti M, La Civita L, Careccia G, Longombardo G, Lombardini F, Bombardieri S, Gentilini P: Hepatitis C virus genotype analysis in patients with type II mixed cryoglobulinemia. Ann Intern Med 1996, 124:31-34.
66. 66 Zignego AL, Giannelli F, Marrocchi ME, Giannini C, Gentilini P, Innocenti F, Ferri C: Frequency of bcl-2 rearrangement in patients with mixed cryoglobulinemia and HCV-positive liver diseases. Clin Exp Rheumatol 1997, 15:711-712.
67. 67 Zignego AL, Giannelli F, Marrocchi ME, Mazzocca A, Ferri C, Giannini C, et al: T(14;18) translocation in chronic hepatitis C virus infection. Hepatology 2000, in press. Important molecular biology study demonstrating the possible role of genetic aberration in the pathogenesis of HCV-related autoimmune-lymphoproliferative disorders.
68. 68 Korsmeyer SJ: Bcl-2: a repressor of lymphocyte death. Immunol Today 1992, 13:285-287.
69. 69 Valentini G, Mantelli A, Persico M, Tuccillo C, Del Vecchio Blanco G, Morisco F, Improta RD, Migliaresi S, Gualdieri L, Caporaso N: Serological and clinical markers of autoimmune disease in HCV-infected subjects with different disease conditions. Clin Exp Rheumatol 1999, 17:75-79.
70. 70 Cacoub P, Poynard T, Ghillani P, Charlotte F, Olivi M, Piette JC, Opolon P for the MULTIVIRC Group: Extrahepatic manifestations of chronic hepatitis C. Arthritis Rheum 1999; 42:2204-2212. This interesting clinical study evaluated the prevalence of extrahepatic manifestations of HCV infection in a large series of French patients.
71. 71 Pileri P, Uematsu Y, Campagnoli S, Galli G, Falugi F, Petracca R, Weiner AJ, Houghton M, Rosa D, Grandi G, Abrignani S: Binding of hepatitis C virus to CD81. Science 1998, 282:938-941. Excellent molecular biology study demonstrating the role of CD81 molecule in the binding of HCV to both hepatocytes and lymphocytes.
72. 72 Abrignani S, Rosa D: Perspectives for a hepatitis C virus vaccine. Clin Diagn Virol 1998, 10:181-185.
73. 73 McHutchison JG, Gordon SC, Schiff ER, Shiffman ML, Lee WM, Rustgi VK, Goodman ZD, Ling MH, Cort S, Albrecht JK: Interferon alpha-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group. N Engl J Med 1998, 339:1485-1492. Important demonstration of the usefulness of interferon-ribavirin combined therapy in HCV-related hepatitis.